Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

Documenti analoghi

• Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
  di: Gros, Alena, et al.
  Pubblicazione: (2016)
• Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
  di: Yossef, Rami, et al.
  Pubblicazione: (2018)
• Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
  di: Cohen, Cyrille J., et al.
  Pubblicazione: (2015)
• Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
  di: Crystal, Jessica S, et al.
  Pubblicazione: (2015)
• T-cell responses to TP53 “hotspot” mutations and unique neoantigens expressed by human ovarian cancers
  di: Deniger, Drew C., et al.
  Pubblicazione: (2018)